PIII (P3 Health Partners) 3-Year RORE % : 7.08% (As of Mar. 2026)


PIII P3 Health Partners Inc PIII
47 GF Score
Price $10.28
GF Value $9.22
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is P3 Health Partners 3-Year RORE %?

P3 Health Partners PIII -9.50% 47 3-Year RORE % is 7.08 as of Mar. 2026. GuruFocus rates PIII with a GF Score™ of 47/100 and a GF Value™ of $9.22 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 605 Healthcare Providers & Services companies, P3 Health Partners ranks better than 57.52% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. P3 Health Partners's 3-Year RORE % for the quarter that ended in Mar. 2026 was 7.08%.

The industry rank for P3 Health Partners's 3-Year RORE % or its related term are showing as below:

PIII's 3-Year RORE % is ranked better than
57.52% of 605 companies
in the Healthcare Providers & Services industry
Industry Median: -0.32 vs PIII: 7.08

P3 Health Partners  (NAS:PIII) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


P3 Health Partners 3-Year RORE % Related Terms


P3 Health Partners 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for P3 Health Partners's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

P3 Health Partners 3-Year RORE % Chart

P3 Health Partners Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial 0.00 99.93 -0.04 -99.88 9.17

P3 Health Partners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -99.89 -99.89 -99.89 9.17 7.08

PIII vs EHSI, CDIX, DCGO: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, P3 Health Partners's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


P3 Health Partners 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where P3 Health Partners's 3-Year RORE % falls into.


PIII
47GF Score
P3 Health Partners Inc PIII
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

P3 Health Partners 3-Year RORE % Calculation

P3 Health Partners's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -38.6--30.36 )/( -116.31-0 )
=-8.24/-116.31
=7.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 7.08 mean?
P3 Health Partners (PIII) has a 3-Year RORE % of 7.08 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #257 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 42.5%.
Is P3 Health Partners' 3-Year RORE % too high?
P3 Health Partners' current 3-Year RORE % is 7.08. Based on the distribution chart, P3 Health Partners ranks #257 out of 605 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, P3 Health Partners has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' 3-Year RORE % compare to EHSI and CDIX?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #257 out of 605 companies for 3-Year RORE %. This puts P3 Health Partners in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on P3 Health Partners and its competitors. P3 Health Partners's current 3-Year RORE % is 7.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.22, compared to a current price of $10.28 — trading 11.5% above its estimated fair value. The current 3-Year RORE % is 7.08. P3 Health Partners' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For P3 Health Partners (PIII), the current 3-Year RORE % is 7.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is P3 Health Partners (PIII) Overvalued in 2026?

Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued. The current stock price of $10.28 is trading 11.5% above its estimated GF Value™ of $9.22. GuruFocus considers P3 Health Partners to be Modestly Overvalued.

Key valuation signals for PIII:

  • 3-Year RORE %: 7.08
  • GF Value™: $9.22 vs. price of $10.28 (11.5% above fair value)
  • GF Score™: 47/100 with 7 warning signs

No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


P3 Health Partners Business Description

Address 2370 Corporate Circle, Suite 300, Henderson, NV, USA, 89074
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
47GF Score

Get the complete analysis for PIII

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.28
Price
$9.22
GF Value